Otello Stampacchia - Profile and Investment Details

Investor Profile

Otello Stampacchia is a Venture Capital based in Switzerland with a diverse investment portfolio that includes companies such as FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua, Syros Pharmaceuticals, Jounce Therapeutics, HydrocisionAtea Pharmaceuticals, Develogen AG, eTheRNA immunotherapies, LEXEO Therapeutics, Telesta Therapeutics, Prevail Therapeutics, Nuvation Bio, Editas Medicine, Ardana Bioscience, Orqis Medical, XTuit Pharmaceuticals, Scorpion Therapeutics, Alpine Immune Sciences, GelSight, Dicerna Pharmaceuticals, First Wave Bio, Morphic Therapeutic, Sana Biotechnology, Adagio Therapeutics, Intarcia Therapeutics, Eurobio-Scientific, Andrew Alliance, ImpactRx, BioSilta, Ikena Oncology, ESSA Pharma, Celletra, Median Technologies, Translate Bio, CropDesign, CymaBay Therapeutics, Exenta, Inc., Neurotech, Aquarius Technologies, Replimune Group, Elixir Pharmaceuticals, Checkmate Pharmaceuticals, Imago BioSciences, Icosavax, Visterra, SpineVision, Achaogen, OnPath Technologies, Amunix, Kronos Bio, Immunic, Gossamer Bio, Anaconda BioMed, Kuros Biosciences, JenaValve Technology, Trevi Therapeutics, Egalet, Paratek Pharmaceuticals, Arrakis Therapeutics, DBV Technologies, Kezar Life Sciences, Sienna Biopharmaceuticals, Oxagen, Evotec, Beam Therapeutics, Senti Biosciences, IFM Therapeutics, Chord Therapeutics, Endeavor BioMedicines, ObsEva, Arcutis Biotherapeutics, NeuroVision Imaging, . Over time, Otello Stampacchia has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Otello Stampacchia is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Life Science, Information Technology (IT), Biotechnology, Genomics, Developer Tools, Travel, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Otello Stampacchia, as their portfolio suggests a familiarity and interest in this area.

Understanding Otello Stampacchia’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.